Theriva Biologics, Inc. (TOVX) Tops Q3 EPS by 23c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($0.19), $0.23 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c